Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like Cancer Biotech G1 Therapeutics Grabs $105 Million in IPO May 16, 2017 Galapagos' Phase II Results With GLPG1690 are 'Extremely Exciting' August 9, 2017 Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics July 19, 2017
Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics July 19, 2017
